Income Statement
Quarterly Data
The income statement presents information on the financial results of a company business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.
Paying user area
Try for free
Regeneron Pharmaceuticals Inc. pages available for free this week:
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Regeneron Pharmaceuticals Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Regeneron Pharmaceuticals Inc., consolidated income statement (quarterly data)
US$ in thousands
Based on: 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).
- Revenue Trends
- The total revenues of the company demonstrate substantial variability across the quarters from March 2020 through September 2025. Net product sales show an overall growth trend with notable spikes in mid-2021 and some fluctuation thereafter. Collaboration revenue also indicates strong intermittent increases, peaking especially in late 2022 and mid-2025. Other revenue fluctuates with noticeable volatility, without a clear upward or downward trajectory.
- Cost of Revenues
- The combined cost of goods sold and cost of collaboration and contract manufacturing display significant fluctuations. Costs sharply increase in the second half of 2020 and early 2021, reflecting substantial rises in production or collaboration expenses. After some decline, costs again ascent towards the later periods, showing a pattern of increasing operational expenditure aligning with revenue trends but also indicating potential pressures on margin maintenance.
- Gross Profit
- Gross profit follows a broadly positive trend despite cost fluctuations, rising significantly in 2021 in line with revenue growth. After a slight decline in 2022, gross profit stabilizes at relatively high levels, reflecting effective revenue generation and potential cost management, but with some risk due to sporadic cost increases.
- Research and Development Expenses
- Research and development (R&D) costs consistently increase over the period, with intermittent spikes, especially pronounced towards the end of 2022 and into 2024. The inclusion of an acquired in-process R&D expense further elevates total R&D costs intermittently, suggesting ongoing investment in innovation, pipeline development, or acquisitions, representing a substantial and growing portion of operating expenses.
- Selling, General, and Administrative Expenses
- SG&A expenses show a gradual upward trend with some variability, peaking notably toward the end of 2021 and maintaining elevated levels thereafter. This pattern indicates increasing selling and administrative efforts, possibly related to scaling operations or marketing activities, which also exert pressure on operating margins.
- Operating Income
- Income from operations reflects strong growth through 2021, paralleling revenue and gross profit increases. However, following the peak period, operating income declines substantially in 2022 and remains variable with moderate recovery attempts. This suggests that cost increases, particularly in R&D and SG&A, are impacting operational profitability despite sustained revenue levels.
- Other Income and Expenses
- Other income (expense), net, exhibits notable volatility with both positive and negative swings, including significant positive influxes during some quarters in 2021, 2022, and mid-2024. Interest expense remains relatively stable and low, implying manageable debt levels or favorable financing conditions. The irregular nature of other net income components suggests occasional gains or losses potentially from investments, collaborations, or extraordinary items impacting bottom-line results.
- Income Before Taxes and Net Income
- Income before income taxes generally follows the trends observed in operating income and other income (expense), showing high peaks in 2021 and variable performance subsequently. Net income, while positive throughout the period, fluctuates considerably, reflecting the influences of both operational performance and tax expense volatility. Notably, the company experiences a significant rise in net income in 2021, followed by reductions and some recovery phases, highlighting the interplay between revenues, costs, and tax effects on profitability.
- Income Tax Expense
- Income tax expenses vary widely, with some quarters showing tax benefits or credits. The fluctuations in tax expense partially affect net income stability and underline the influence of changing pre-tax income and possible tax planning or adjustments within the periods analyzed.